Yohimbine
- Level
- Commodity
- Parent
- 51263400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263401This classification denotes an alpha-adrenergic blocking agent with the molecular formula C21H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Y49VWD90Q, chemically known as 20.alpha.-yohimban-16.beta.-carboxylic acid, 17.alpha.-hydroxy-, methyl ester, monohydrochloride but generally known as yohimbine, which bears US NIH Compound Identifier 2866. European Medicines Agency schedules Yohimbine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15744MIG. World Health Organization schedules yohimbine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule yohimbine under HS 29399990 and SITC 54149. As of Q4 2014, YOHIMBINE remains the US FDA Preferred Term for this commodity. Yohimbine bears US NLM identifiers UMLS ID C0724441 and NCI Concept Code C77304. SMILES: OC1C(C2C(CN3C(C2)C2[NH]C4C(C2CC3)CCCC4)CC1)C(=O)OC.
Same parent
Under 51263400 · 7Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.